CpG island methylator phenotype (CIMP) in microsatellite stable colorectal cancers; Differences between existing CIMP and newly described

被引：0
|
作者：
Lee, S.
Park, S. Y.
Kim, J. H.
Cho, N. Y.
Choi, M. H.
Yoo, E. J.
Kang, G. H.
机构：
[1] Kyung Hee Univ, Sch Med, Seoul, South Korea
[2] Seoul Natl Univ, Coll Med, Seoul, South Korea
来源：
LABORATORY INVESTIGATION | 2007年 / 87卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
540
引用
收藏
页码：120A / 121A
页数：2
相关论文
共 50 条
  • [31] Identification of a CpG-island methylator phenotype (CIMP) in a subgroup of pilocytic astrocytoma with favorable prognosis
    Witt, Hendrik
    Zapatka, Marc
    Jones, David W.
    Huriye, Cin
    Remke, Marc
    Janzarik, Wibke
    Gnekow, Astrid
    Witt, Olaf
    Lichter, Peter
    Korshunov, Andrey
    Pfister, Stefan M.
    CANCER RESEARCH, 2011, 71
  • [32] CpG island methylator phenotype (CIMP) and P53 methylation patterns in Puerto Rican Hispanic colorectal cancer patients
    Castro, Cristina I.
    Lacourt, Mercedes Y.
    Bernabe, Raul Ft
    Cruz-Correa, Marcia R.
    CANCER RESEARCH, 2010, 70
  • [33] Kidney tumors associated with germline mutations of FH and SDHB show a CpG island methylator phenotype (CIMP)
    Ricketts, Christopher J.
    Killian, J. Keith
    Vocke, Cathy D.
    Wang, Yonghong
    Merino, Maria J.
    Meltzer, Paul S.
    Linehan, W. Marston
    PLOS ONE, 2022, 17 (12):
  • [34] CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies
    Ogino, S.
    Cantor, M.
    Kawasaki, T.
    Brahmandam, M.
    Kirkner, G. J.
    Weisenberger, D. J.
    Campan, M.
    Laird, P. W.
    Loda, M.
    Fuchs, C. S.
    GUT, 2006, 55 (07) : 1000 - 1006
  • [35] CpG Island Methylator Phenotype in Colorectal Cancers Comparison of the New and Classic CpG Island Methylator Phenotype Marker Panels
    Lee, Sun
    Cho, Nam-Yun
    Yoo, Eun Joo
    Kim, Jung Ho
    Kang, Gyeong Hoon
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2008, 132 (10) : 1657 - 1665
  • [36] Determination of CpG island methylator phenotype (CIMP) status of colon cancer in plasma using Droplet Digital PCR
    Jiang, J.
    Hao, L.
    Sun, X.
    Wu, K.
    Fang, C.
    Yan, H.
    CLINICAL & EXPERIMENTAL METASTASIS, 2017, 34 (3-4) : 224 - 224
  • [37] Distinct microbiome in colorectal cancers with the CpG Island Methylator Phenotype
    Sun, Ang
    Cesaroni, Matteo
    Jobin, Christian
    Barrero, Carlos
    Jelinek, Jaroslav
    Sautter, Jacqueline D.
    Rams, Thomas E.
    Merali, Salim
    Issa, Jean-Pierre
    CANCER RESEARCH, 2015, 75
  • [38] CpG island methylator phenotype identifies high risk patients among microsatellite stable BRAF mutated colorectal cancers
    Vedeld, Hege Marie
    Merok, Marianne
    Jeanmougin, Marine
    Danielsen, Stine A.
    Honne, Hilde
    Presthus, Gro Kummeneje
    Svindland, Aud
    Sjo, Ole H.
    Hektoen, Merete
    Eknaes, Mette
    Nesbakken, Arild
    Lothe, Ragnhild A.
    Lind, Guro E.
    INTERNATIONAL JOURNAL OF CANCER, 2017, 141 (05) : 967 - 976
  • [39] CpG island methylator phenotype-low (CIMP-Low) in colorectal cancer:: Possible associations with male sex and KRAS mutations
    Ogino, Shuji
    Kawasaki, Takako
    Kirkner, Gregory J.
    Loda, Massimo
    Fuchs, Charles S.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2006, 8 (05): : 582 - 588
  • [40] Identification of tumors with CpG island methylator phenotype (CIMP) based on TCGA genome-wide methylation profiling
    Fedorova, M.
    Krasnov, G.
    Kharitonov, S.
    Snezkina, A.
    Pudova, E.
    Dmitriev, A.
    Chernichenko, M.
    Sidorov, D.
    Alexeev, B.
    Kudryavtseva, A.
    FEBS OPEN BIO, 2018, 8 : 450 - 450
12345